MedPath

Clinical Study for the Treatment of Pelvic Organ Prolapse by Integrated Traditional Chinese and Western Medicine

Phase 1
Conditions
Pelvic organ prolapse
Registration Number
ITMCTR2000002911
Lead Sponsor
The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) Women aged 50-70 years.
(2) There is no neuromuscular disease caused by other factors, and cognitive ability is normal.
(3) Meet the diagnostic criteria for pelvic organ prolapse I and II;
(4) Comply with the syndrome differentiation criteria of Yin Ting Qi Deficiency;
(5) No history of hormone use in the past 3 months;
(6) Informed consent and cooperation with inspection and treatment.

Exclusion Criteria

(1) History of symptoms such as urination, chronic bronchitis, and urogenital infections.
(2) Previous history of pelvic surgery or transvaginal surgery.
(3) Malignant lesions of the reproductive system or diseases that can cause abnormal vaginal secretions (such as cervical cancer, endometrial cancer, fallopian tube cancer, CIN II or above, and acute pelvic inflammatory disease, etc.).
(4) Patients with severe diseases such as cardiovascular, liver, kidney and hematopoietic system or mental illness.(5) Patients with vaginal wall cysts.
(6) Patients who fail to treat as required, cannot judge the efficacy or have incomplete data, etc., which affect the effect observation.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in pelvic floor muscle strength;Pelvic organ POP-Q score;
Secondary Outcome Measures
NameTimeMethod
TCM Symptom Score;
© Copyright 2025. All Rights Reserved by MedPath